[1]
Su, Y. et al. 2007. Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan. Journal of Pharmacy & Pharmaceutical Sciences. 10, 4 (Oct. 2007), 519–536. DOI:https://doi.org/10.18433/J3QP4W.